Amino Acids for Sarcopenia

(BOOST_CKD Trial)

SD
Overseen BySubrata Debnath, PhD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: The University of Texas Health Science Center at San Antonio
Must be taking: SGLT2-i, GLP-1 agonist
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Sarcopenia, or loss of muscle and strength is common in patients with poor kidney function. Although a high protein diet is generally recommended for sarcopenia, patients with poor kidney function are advised to follow a low-protein diet. In this study, we will evaluate the practicality and potential benefits of two different amino acids (molecules that form proteins) in improving sarcopenia in patients with advanced kidney disease.

The study aims to improve muscle mass and strength. All study procedures are free of cost and do not require significant time commitment. You will have time to ask questions and discuss the study with your family, primary care physician, and your kidney doctor to make the decision if this is right study for you to participate in.

Who Is on the Research Team?

SD

Subrata Debnath, PhD

Principal Investigator

The University of Texas Health Science Center at San Antonio

Are You a Good Fit for This Trial?

Inclusion Criteria

I am not on dialysis and do not expect to need it in the next 4 months.
I understand the study and am willing to sign a consent form.
My hand grip strength is below 26 kg (male) or 16 kg (female).
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive daily oral consumption of either 2 g valine or 20 g essential amino acids (EAA) for 6 weeks

6 weeks
Regular monitoring visits

Follow-up

Participants are monitored for safety and effectiveness after treatment

8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • EEA
  • Valine

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Treatment group ValineExperimental Treatment1 Intervention
Group II: Treatment group EEAExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center at San Antonio

Lead Sponsor

Trials
486
Recruited
92,500+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+